Format
Sort by
Items per page

Send to

Choose Destination

Best matches for curcumin alzheimer's:

Search results

Items: 1 to 20 of 629

1.

Curcumin Alleviates β Amyloid-Induced Neurotoxicity in HT22 Cells via Upregulating SOD2.

Du S, Zhang Y, Yang J, Liu X, Wang Y, Xu B, Jia J.

J Mol Neurosci. 2019 Feb 12. doi: 10.1007/s12031-019-01267-2. [Epub ahead of print]

PMID:
30746607
2.

Formulations of Curcumin Nanoparticles for Brain Diseases.

Del Prado-Audelo ML, Caballero-Florán IH, Meza-Toledo JA, Mendoza-Muñoz N, González-Torres M, Florán B, Cortés H, Leyva-Gómez G.

Biomolecules. 2019 Feb 8;9(2). pii: E56. doi: 10.3390/biom9020056. Review.

3.

Antioxidants: Scientific Literature Landscape Analysis.

Yeung AWK, Tzvetkov NT, El-Tawil OS, Bungǎu SG, Abdel-Daim MM, Atanasov AG.

Oxid Med Cell Longev. 2019 Jan 8;2019:8278454. doi: 10.1155/2019/8278454. eCollection 2019. Review.

4.

Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration.

Kuo YC, Chen CL, Rajesh R.

Acta Biomater. 2019 Feb 1. pii: S1742-7061(19)30087-X. doi: 10.1016/j.actbio.2019.01.065. [Epub ahead of print]

PMID:
30716553
5.

Apolipoprotein E Polymorphism and Oxidative Stress in Peripheral Blood-Derived Macrophage-Mediated Amyloid-Beta Phagocytosis in Alzheimer's Disease Patients.

Jairani PS, Aswathy PM, Krishnan D, Menon RN, Verghese J, Mathuranath PS, Gopala S.

Cell Mol Neurobiol. 2019 Jan 29. doi: 10.1007/s10571-019-00651-1. [Epub ahead of print]

PMID:
30694418
6.

Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of Alzheimer's disease: Are combinations more effective?

Sharman MJ, Gyengesi E, Liang H, Chatterjee P, Karl T, Li QX, Wenk MR, Halliwell B, Martins RN, Münch G.

Neurobiol Dis. 2019 Apr;124:505-519. doi: 10.1016/j.nbd.2018.11.026. Epub 2019 Jan 2.

PMID:
30610916
7.

Design of novel amyloid β aggregation inhibitors using QSAR, pharmacophore modeling, molecular docking and ADME prediction.

Aswathy L, Jisha RS, Masand VH, Gajbhiye JM, Shibi IG.

In Silico Pharmacol. 2018 Jun 15;6(1):12. doi: 10.1007/s40203-018-0049-1. eCollection 2018.

PMID:
30607325
8.

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas.

den Haan J, Morrema THJ, Verbraak FD, de Boer JF, Scheltens P, Rozemuller AJ, Bergen AAB, Bouwman FH, Hoozemans JJ.

Acta Neuropathol Commun. 2018 Dec 28;6(1):147. doi: 10.1186/s40478-018-0650-x.

9.

Liposome delivery systems for the treatment of Alzheimer's disease.

Ross C, Taylor M, Fullwood N, Allsop D.

Int J Nanomedicine. 2018 Dec 12;13:8507-8522. doi: 10.2147/IJN.S183117. eCollection 2018. Review.

10.

Curcumin intervention for cognitive function in different types of people: A systematic review and meta-analysis.

Zhu LN, Mei X, Zhang ZG, Xie YP, Lang F.

Phytother Res. 2018 Dec 21. doi: 10.1002/ptr.6257. [Epub ahead of print] Review.

PMID:
30575152
11.

Emerging Anti-Aging Strategies - Scientific Basis and Efficacy.

Shetty AK, Kodali M, Upadhya R, Madhu LN.

Aging Dis. 2018 Dec 4;9(6):1165-1184. doi: 10.14336/AD.2018.1026. eCollection 2018 Dec. Review.

12.

A Computational Study of the Driving Forces and Dynamics of Curcumin Binding to Amyloid-β Protofibrils.

Martin TD, Malagodi AJ, Chi EY, Evans DG.

J Phys Chem B. 2018 Dec 20. doi: 10.1021/acs.jpcb.8b09185. [Epub ahead of print]

PMID:
30571122
13.

New amyloid beta-disaggregating agents: synthesis, pharmacological evaluation, crystal structure and molecular docking of N-(4-((7-chloroquinolin-4-yl)oxy)-3-ethoxybenzyl)amines.

Umar T, Shalini S, Raza MK, Gusain S, Kumar J, Ahmed W, Tiwari M, Hoda N.

Medchemcomm. 2018 Aug 20;9(11):1891-1904. doi: 10.1039/c8md00312b. eCollection 2018 Nov 1.

PMID:
30568757
14.

Inverse Molecular Docking as a Novel Approach to Study Anticarcinogenic and Anti-Neuroinflammatory Effects of Curcumin.

Furlan V, Konc J, Bren U.

Molecules. 2018 Dec 18;23(12). pii: E3351. doi: 10.3390/molecules23123351.

15.

Biological clocks, some clock-related diseases, and medicinal plants.

Deng TS.

Psych J. 2018 Dec;7(4):197-205. doi: 10.1002/pchj.263. Review.

PMID:
30561856
16.

Curcumin and Novel Synthetic Analogs in Cell-Based Studies of Alzheimer's Disease.

Gagliardi S, Franco V, Sorrentino S, Zucca S, Pandini C, Rota P, Bernuzzi S, Costa A, Sinforiani E, Pansarasa O, Cashman JR, Cereda C.

Front Pharmacol. 2018 Dec 3;9:1404. doi: 10.3389/fphar.2018.01404. eCollection 2018.

17.

PRENYLATED CURCUMIN ANALOGUES AS MULTIPOTENT TOOLS TO TACKLE ALZHEIMER'S DISEASE.

Bisceglia F, Seghetti F, Serra M, Zusso M, Gervasoni S, Verga L, Vistoli G, Lanni C, Catanzaro M, De Lorenzi E, Belluti F.

ACS Chem Neurosci. 2018 Dec 17. doi: 10.1021/acschemneuro.8b00463. [Epub ahead of print]

PMID:
30556996
18.

Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype.

Pluta R, Ułamek-Kozioł M, Czuczwar SJ.

Int J Mol Sci. 2018 Dec 12;19(12). pii: E4002. doi: 10.3390/ijms19124002. Review.

19.

Phenylpropanoids and lignans from Prunus tomentosa seeds as efficient β-amyloid (Aβ) aggregation inhibitors.

Liu Q, Wang J, Lin B, Cheng ZY, Bai M, Shi S, Huang XX, Song SJ.

Bioorg Chem. 2019 Mar;84:269-275. doi: 10.1016/j.bioorg.2018.11.041. Epub 2018 Nov 26.

PMID:
30529844
20.

Oxidation of cystatin imparted by riboflavin generated free radicals: Spectral analysis.

Amin F, Khan W, Bano B.

Int J Biol Macromol. 2019 Mar 1;124:1281-1291. doi: 10.1016/j.ijbiomac.2018.12.021. Epub 2018 Dec 3.

PMID:
30521904

Supplemental Content

Loading ...
Support Center